Is KMS Medisurgi overvalued or undervalued?
As of July 23, 2025, KMS Medisurgi is considered very expensive and overvalued, with a high PE ratio of 39.77 and a year-to-date return of -3.6%, indicating it trades at a premium compared to its peers and has no growth expectations.
As of 23 July 2025, KMS Medisurgi's valuation grade has moved from risky to very expensive. The company is currently overvalued, as indicated by its high PE ratio of 39.77, an EV to EBIT of 39.89, and a Price to Book Value of 5.19. These ratios suggest that the stock is trading at a premium compared to its earnings and book value.In comparison to its peers, KMS Medisurgi's PE ratio is lower than Poly Medicure's 62.49 but higher than Blue Jet Health's 39.49, which also has a significantly lower EV to EBITDA of 30.53. Additionally, while KMS Medisurgi has a PEG ratio of 0.00, indicating no growth expectations, its peers like Vimta Labs and Prevest Denpro, with PEG ratios of 0.66 and 2.73 respectively, suggest a more favorable growth outlook. The recent performance of KMS Medisurgi, with a year-to-date return of -3.6% compared to the Sensex's 5.87%, reinforces the notion that the stock is currently overpriced.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
